The 31-GEP Stratifies Risk of Death in Patients with Stage I-IIA Cutaneous Melanoma: A SEER Real-World Evidence Study. J of Skin [Internet]. 2025 Jul. 23 [cited 2025 Nov. 16];9(4):s586. Available from: https://skin.dermsquared.com/skin/article/view/3523